Remnant cholesterol is an effective biomarker for predicting survival in patients with breast cancer.

导出 OA

翻译打印收藏纠错

作者： Jinyu,Shi ^[1] ; Tong,Liu ^[2] ; Chenan,Liu ^[3] ; Heyang,Zhang ^[4] ; Guotian,Ruan ^[1] ; Hailun,Xie ^[2] ; Shiqi,Lin ^[3] ; Xin,Zheng ^[4] ; Yue,Chen ^[1] ; Qi,Zhang ^[2] ; Xiaowei,Zhang ^[3] ; Xiangrui,Li ^[4] ; Xiaoyue,Liu ^[1] ; Li,Deng ^[2] ; Han-Ping,Shi ^[3]

作者单位： Department of Gastrointestinal Surgery, Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China. ^[1] National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China. ^[2] Laboratory for Clinical Medicine, Capital Medical University, Beijing, 100053, China. ^[3] Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, 100038, China. ^[4] Department of Genetics, Yale School of Medicine, New Haven, CT, 06510, USA. ^[5] Department of Gastrointestinal Surgery, Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China. shihp@ccmu.edu.cn. ^[6] National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China. shihp@ccmu.edu.cn. ^[7] Laboratory for Clinical Medicine, Capital Medical University, Beijing, 100053, China. shihp@ccmu.edu.cn. ^[8] Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, 100038, China. shihp@ccmu.edu.cn. ^[9]

关键词 Biomarker Breast cancer Prognosis Remnant cholesterol